兰卫医学 (301060)
Shanghai Labway Clinical Laboratory Co.,Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Labway Medical Laboratory Co., Ltd.
Listing Date2021-09-13
Issue Price4.17RMB
Registered Capital40051.710k RMB
Legal RepresentativeZeng Weixiong
Registered AddressFloors 4-9, Building 1, Lane 268, Linxin Road, Changning District, Shanghai
IndustryMedical Services
Main BusinessA comprehensive service provider offering integrated solutions for the testing and diagnostics industry. It provides third-party medical testing and pathological diagnosis services, in-vitro diagnostic products from well-known domestic and international brands, and other professional technical support to medical institutions at all levels, catering to their differentiated needs.
Company ProfileShanghai Labway Medical Laboratory Co., Ltd. (abbreviated as Labway Testing) is a high-tech enterprise that provides comprehensive health management solutions based on medical testing and pathological diagnosis services. Through a business model combining third-party medical diagnostic services and the sales of in-vitro diagnostic products, the company empowers medical technology laboratories such as hospital testing departments, pathology departments, and central laboratories, helping them reduce operational costs and risks while improving the quality of medical services and technical capabilities.
Currently, the company's business covers over ten provinces and municipalities, with more than ten regional medical testing and pathological diagnosis centers established, forming a branded, scaled, and standardized laboratory network. In the field of medical testing and pathological diagnosis, Labway Testing possesses extensive experience in operating independent medical laboratories and has successively obtained ISO15189 international standard accreditation, as well as CAP and CMA certifications. In 2007, Labway Testing signed an agreement with the Shanghai Changning District Health and Family Planning Commission to jointly establish the 'Changning Regional Testing Center.' This initiative marked the first nationwide realization of regionalized testing services, creating the 'Changning Model' for national community healthcare reform and becoming one of the landmark events in the development of China's health service industry.
Stock Details
1. Key Indicators
- Total Shares(W): 40051.70
- Circulating A-Shares(W): 36018.46
- Earnings Per Share(RMB): -0.0017
- Net Assets Per Share(RMB): 3.9393
- Operating Revenue(W RMB): 110209.57
- Total Profit(W RMB): 2144.82
- Net Profit Attributable to Parent(W RMB): -66.77
- Net Profit Growth Rate(%): 98.35
- Weighted Return on Equity(%): -0.0400
- Operating Cash Flow Per Share(RMB): 0.4290
- Undistributed Profit Per Share(RMB): 1.3992
- Capital Reserve Per Share(RMB): 1.3831
2. Main Business
The main business covers:
- Providing integrated solutions for the medical diagnostics industry
3. Company Basic Information
- Company Name: Shanghai Labway Clinical Laboratory Co., Ltd.
- Listing Date: 2021-09-13
- Industry: Medicine & Healthcare - Medical Services
- Address: Floors 6, 7, 8, 9, Building 1, No. 268 Lane, Linxin Road, Changning District, Shanghai, China
- Website: www.labway.cn
- Company Profile: On August 4, 2015, all shareholders of Labway Limited jointly signed the "Sponsor Agreement on the Establishment of Shanghai Labway Clinical Laboratory Co., Ltd.", agreeing to contribute the audited net assets as of May 31, 2015 as capital contribution to wholly change into Shanghai Labway Clinical Laboratory Co., Ltd. On September 7, 2015, the company completed the industrial and commercial change registration procedures for this overall change and obtained the "Business License" with the Unified Social Credit Code 91310000669421384T.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Lanwei Investment Co., Ltd. | General Legal Person | 14955.40 | 41.52 |
| 2 | Hailan Group Co., Ltd. | General Legal Person | 1446.51 | 4.02 |
| 3 | Shanghai Huikun Investment Management Center (Limited Partnership) | General Legal Person | 1335.00 | 3.71 |
| 4 | BARCLAYS BANK PLC | QFII | 152.64 | 0.42 |
5. Concept Sectors
- Gene Concept
- Artificial Intelligence
- CXO Concept
- Helicobacter Pylori
- Assisted Reproduction
- Hepatitis Concept
- Margin Trading & Securities Lending
- Consecutive Losses
- QFII New Entry
- Specialized, Sophisticated, Distinctive, and Innovative SMEs
- Micro & Small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information